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ABSTRACT 
 
In this thesis a series of diphenol phenanthroline (Dpp) peptide conjugates were synthesized and 
then coupled to ferrocene to give the corresponding organometallic conjugates.  The first step of 
the synthesis was achieved by esterification of peptides with the phenol group of the Dpp.  The 
next step was the removal of the protecting Boc group and the addition of ferrocene acid chloride 
at high dilutions to give the desired macrocycles of the type Dpp-(peptide)2 Fc. (peptide = Leu-
Leu (3), Leu-Leu-Leu (5) ).  However, the syntheses proceeded in low yields where only small 
quantities of the desired products were obtained. A suitable crystal of compound 3 was grown 
from CHCl3 which shows a number of intra and intermolecular hydrogen bonding interactions 
between peptides strands.In addition, the system [Dpp-Fc]2 (1) was syntheised by refluxing Dpp 
and Fc[COCl]2 in dichloromethane. A suitable crystal was grown which has π-π interactions 
between intramolecular Dpp units as well as a number of CH-π interactions which determine the 
crystal packing.  The electrochemical experiments on compound 1 show a cathodic shift upon 
addition of Zn
2+
 to a solution of 1.  This observation is believed to occur because of a 
conformational change in 1. 
The last area of synthesis that was done was the attempt at β-sheet formation using Fc as a 
scaffold to align peptide strands.  Two systems were studied in this thesis [Fc(n’-AA-OMe)(1-
AA)]2-1,4butyl diamine. (AA =Ala (8), Gly (9)).  Both were studied by 
1
H NMR to evaluate the 
presence of hydrogen bonding interactions.  The results indicate the presence of intramolecular 
H-bonding, which is believed to form β-sheet like structures in solution.   
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CHAPTER 1. 
INTRODUCTION 
 
1.1 PEPTIDES 
The dictionary defines a peptide as “two or more amino acids by combination of the 
amino group of one acid with the carboxyl group of another”.1 In this definition the term 
amino acid (AA) is used as component of a larger molecule.  α-Amino acids are natural 
products that are comprised of an amino group and a carboxyl acid group both bound to a 
common carbon atom and a side chain usually denoted by R. This side chain alters the 
physical properties of the amino acid, such as its solubility, and influences the spatial 
orientation of a growing peptide chain.  Figure 1.1 shows a few amino acids.  
 
 
 
 
 
 
Figure 1.1. Drawing of glycine (Gly), alanine (Ala), valine (Val), leucine (Leu), and 
isoleucine (Ile).  
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2 
 
All naturally occurring α-amino acids, except for glycine (Gly), have a stereogenic 
αC which creates the possibility of stereoisomers.  The two isomers are denoted as L and 
D and, using Ala as an example, are shown in Figure 1.2.  The L-isomer is common in 
Nature, while the D amino acids are less common.
2
  
 
 
 
 
 
 
Figure 1.2. Drawing of L-Alanine and D-Alanine. When stereochemistry is not 
explicitly shown it is assumed that the amino acid drawn is an L-AA.  
 
As amino acids are coupled together, either by enzymatic reactions or synthetic coupling 
reactions, amide bonds or peptide bonds are formed between the amide of one amino acid 
and the carboxyl group of the second amino acid (Figure 1.3). Coupling reagents can be 
described as activating compounds used in the synthesis of peptide bonds and a number 
of common agents will be discussed later in this thesis. 
 
 
 
  
 
Figure 1.3.  Reaction of two amino acids with side chains denoted by R using coupling 
reagents to form a peptide bond between the acid group of one amino acid and the amine 
group of the other amino acid. 
 
 
As amino acids are coupled, they form a linear peptide strand. This peptide strand can 
then arrange into various secondary structures, stabilized by intramolecular hydrogen 
bonding interactions and the steric demand of the amino acid side chains.  Hydrogen 
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bonding in peptide strands is the leading factor in folding of peptides and dictates the 
overall secondary structure. Common secondary structural elements found in proteins, 
including a β-sheet, an α-helix and various turns are shown in Figure 1.4. As secondary 
structures interact, a preferred structure is formed, which in turn determines the overall 
properties or the protein.   
 
Figure 1.4. a) β-sheet showing hydrogen bonding between strands b) α-helix, 
hydrogen bonding is on the outside of the helix with every 4
th
 amino acid hydrogen 
bonded c) α, β, and γ turns where hydrogen bonding is between amide and carboxyl 
group of opposite side of the turn 
 
In contrast to the “normal” linear peptide chains that are formed by amide bonds, 
there is the possibility of forming cyclic peptides or cyclopeptides.  Cyclopeptides occur 
when the amine and the carboxyl of the same peptide form an intramolecular amide bond 
that leads to ring closure.  The properties, structure, and synthesis of both naturally 
occurring as well as synthetic cyclopeptides will be discussed in the next section.  
 
1.2 CYCLOPEPTIDES 
 The conventional picture of a protein is series of amino acids in a linear chain 
with a number of secondary elements giving rise to both structure and properties. While 
this is an accurate description for most proteins, there have been recent discoveries on the 
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presence of cyclic proteins.  There have been discoveries of cyclopeptides occurring in 
sources of plants, bacteria and even some animals,
3
 which range in size from 14
4
 to 78
5
 
amino acids in size.  Figure 1.5 shows three isolated cyclopeptides from mammalian, 
plant, and bacterial sources. 
 
 
 
 
 
 
 
Figure 1.5 Cyclopeptides and small cyclic proteins isolated from bacterial, plant and 
mammalian sources. The structures shown were obtained by solution NMR studies. a) 
Protein rhesus θ-defensin–1 isolated from macaques monkeys.  Three disulfide bonds in 
this small cyclopeptide give it both stability and rigidity. b) Cyclotide protein kalata B1 
isolated from the plant Oldenlandia affinis.  c) AS-48 bacterial protein isolated from 
Enterococcus Faecalis is currently being test as a food additive as well as uses in 
veterinary medicine as an anti bacterial protein.
6,7
      
 
 
 
 
 
Cyclopeptides have inherently different properties compared to their linear 
peptide counterparts. For example, their hydrolytic stability has been shown to be 
greater.
3
  While degradation of natural proteins happen by enzymatic reactions using a 
number of exopeptidase enzymes, cyclopeptides do not contain an amino or carboxy 
terminal side for exopeptidase (aminopeptidases or carboxypeptidases) to attach, 
therefore degradation by exopeptidases does not occur to cyclic peptides.
7
 In addition 
cyclopeptides differ in their stability to extreme temperatures and pH.
7
 Research has 
shown that bioactivity is still present in bacteriocin AS-48 at its biologically active 
b) a) c) 
5 
 
temperature after being exposed to temperatures near 93°C,
8
 this is significantly higher 
than most linear proteins whose biological activity ceases at roughly 50°C.
 
 The activity 
is preserved because of the ability of the cyclic peptides to fold back into the active state, 
while linear peptides will deform and cannot refold into its active form.  As well as the 
increased stability of cyclopeptides they have also shown to increase resistance to a 
number of disease and infections, most notably HIV.
9 
 Figure 1.6 shows the chemical 
sequence of rhesus θ-defensin–1 isolated from a macaque monkeys which has shown 
resistance to HIV. One of the most interesting features of cyclic peptides is their potential 
antibacterial properties. It is believed that cyclic peptides are able to incorporate 
themselves into the bacterial membrane, thus disrupting the membrane and decreasing or 
destroying the bacteria.
10
  By combining both stability, as well as the increased activity 
seen in cyclopeptides, new drugs are now being designed to exploit these 
characteristics.
11,12
  
 
 
 
 
 
 
 
Figure 1.6 Chemical sequence of rhesus θ-defensin–1 isolated from macaques13.  The 
HIV resistance protein has directed research to synthesis of cyclopeptide drugs because 
of their inherited stability.  Three disulfide bonds are formed through six cysteine 
residues giving increased stability and rigidity.  
 
 
When discussing cyclopeptides it is important to note that the largest number 
isolated has been from plants.  Plants may contain a large number of cyclic peptides 
because of the harsh conditions they are subjected to as well as the large number of 
bacteria that can be present.  These cyclopeptides, or cyclotides, are described as their 
G
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own subclass.  The requirements of a cyclotide are a head-to-tail cyclization as well as 
disulfide bonds resulting in an increased stability and in many cases knotted topological 
structures.
14 
Cyclotides are believed to have antibacterial, uterotonic, as well as have 
other biological activities.
14
 Although the mechanism of how cyclic peptides act in 
biological systems is still unknown, it is believed that they disrupt cellular membranes.  
Kalata B1 protein, which has been administrated as a tea by an African tribe in the Congo 
for centuries,
7
 has shown an affinity to bind to the membrane of bacteria.  This binding is 
believed to be the mechanism of disruption to the cellular membrane.
15
  
While the properties of cyclopeptides have been understood for a number of 
years, the biosynthetic pathway is often less known.
7
  Although there have been 
advancements in the understanding of gene coding for cyclopeptides, there is still much 
to learn about the enzymes that are present during formation.
7
  The leading theory in 
cyclopeptide formation is that in a linear chain protein, the section that is to be cyclized 
will be cut by an enzyme, which can then either pass off the peptide to another enzyme 
for cyclization or may cyclize the peptide itself.
3
 Because the cyclic structure of the 
proteins are encoded in the genes that form these proteins, gene “grafting” can be used to 
easily synthesis potential highly active drugs.
16
  Other then gene grafting studies on 
cyclopeptides there has also been synthetic research to cyclopeptides.
17-21
Cyclization of 
peptides with varying results of both yield and purity has been reported using many 
different techniques.  Microwave radiation,
13
 metal template assistance,
17
 anion 
templating,
18
 and solid phase synthesis
21
 (Figure 1.7) are examples of techniques used for 
cyclic peptide synthesis.  
 
7 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 Synthetic scheme for solid phase synthesis of a cyclic peptide redrawn from 
reference16.  Disulfide bonds are formed between cystein residues to form the cyclized 
product.
21
 
 
 
 Using a chemical synthetic approach it is possible to incorporate other non-natural 
groups into the sequence that add functionalities and properties such as metal 
coordination sites or the ability to form larger more complex structures. Examples of 
these cyclic pseudopeptides were made by addition of pyridine into a cyclic peptide for 
metal binding,
22
 an addition of a ferrocene (Fc) group for redox properties and to control 
the self-assembly properties of the conjugate,
23
 and substitution of a trifluoromethyl 
group which changes the interactions to studied enzymes (Figure 1.8).
24
 
 
 
 
 
 
 
 
 
 
 
8 
 
Figure 1.8. a) Example of how the addition of pyridine into the cyclic peptide allows for 
metal binding redrawn from reference 22 b) Structure of a cyclic peptide containing a 
ferrocene group redrawn from reference 23.   
 
 
 
1.3 TOPOLOGICALLY LINKED MOLECULES 
 
 Webster’s dictionary defines topology as “the study of geometric configurations 
that are unaltered by elastic deformations.”64  With this being the definition of  topology, 
topologically linked molecules can then be described as two or more independent 
interlocking molecules that cannot be unaltered by elastic deformations.  In the field of 
chemistry there are two main classes of topologically linked molecules that will be 
discussed in this thesis.  The first is the catenanes, which can be seen in Figure 1.9a.  A 
catenane consists of two or more interlocking rings that cannot be separated without 
breaking a covalent bond.  The second class to be discussed is the rotaxanes (Figure 
1.9b).  A rotaxane is described as a cyclic compound that has a linear component running 
through the center of the ring which is then “stoppered” at either end preventing the 
macrocycle from slipping off the linear portion.  Topologically linked molecules have 
been studied in areas of biology as well as material science each of which will be 
discussed briefly. 
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Figure 1.9.  a) Drawing of a catenane where both rings are interlocked with each other.  
b) Drawing of a rotaxane where the linear string goes through the center of the cyclic 
component then is capped on either end. 
 
 
 
1.4 OBJECTIVE AND APPROACH  
 
The objective of research described in this thesis is to prepare cyclic peptide 
conjugates that contain both ferrocene (Fc) and diphenol phenanthroline (Dpp) moieties. 
Such systems are not known to date and may exhibit interesting properties such as metal 
binding as well as redox properties. Research in this thesis will describe my results in this 
area.  
 
  The Fc group is a well known and studied redox probe
25,26 
which is also known 
to specific secondary structures into the conjugate, such a turn-motif. In addition, the Fc 
group will guide and control the hydrogen bonding interactions between the peptide 
substituents.
27,28
  The Dpp group has turn inducing properties,
29
 it can complex metals, 
and has the potential to induce п interactions with adjacent Dpp groups that can lead to 
interesting supramolecular arrangements of the molecules in the solid state.
30
 In this 
thesis, results will be presented that are related to these issues and will show the roles of 
Dpp and of the peptide for the self-association of the molecules in the solid state.   
a) 
b) 
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During the synthesis of cyclic compounds there are a number of problems that can 
occur and need to be addressed.  The order, the speed, and the dilution of the reaction 
mixture will all influence the outcome of the reaction, including the yield of the desired 
cyclic product.  Polymerization of the peptide is the leading concern during cyclization 
reactions and occurs when the kinetics of the intermolecular reaction is faster than that of 
the cyclization.  In any cyclization reactions, mixtures of dimers, trimers and larger 
oligomers will be formed, as well as open chain polymers of increasing chain length.  
The goal of the cyclization reaction is to control any side product reactions so that the 
desired cyclic product is obtained in the highest yield possible.  This can be achieved in a 
number of ways.  Ring closing metathesis,
31
 templating,
32 
high dilution
28 
and 
complexation
33
 are four techniques that have been described in the literature and that 
have given good results. For the cyclization reactions that were preformed in this thesis 
high dilution was combined with slow addition of the reactants.  
 
Figure 1.10.  Cyclization of ferrocene dipeptide using metal complexation from 
reference 31 in DCM. 
   
 The approach to the synthesis of cyclic peptides for this thesis will be first 
coupling a series of amino acids (AA) to Dpp through an ester linkage using 
DCC/DMAP.  This will allow a series of new Dpp-AA compounds to be reported as well 
as metal complexation studies can be done.  The next step in cyclization will be 
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deprotection of Boc and cyclization using ferrocene diacetyl chloride (Fc[COCl]2) at high 
dilutions and slow addition. The acid chloride was selected because of its reactivity with 
the amino group of amino acids. Using the acid chloride method for amide bond 
formation does not require the use of coupling reagents, such as carbodiimides. As new 
compounds are synthesized they are characterized by nuclear magnetic resonance 
(NMR), mass spectrometry (MS), x-ray crystallography and electrochemical studies if a 
redox probe is present. 
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CHAPTER 2. 
NOVEL CYCLIC DIPHENOL PHENANTHROLINE COMPOUNDS 
 
 
 As a first step in this investigation, it was necessary to examine the possibility of 
preparing phenathroline amino acid, peptide, and ferrocene conjugates. This chapter 
focuses on the preparation and the properties of such conjugates.  
  
  
 
2.1 RESULTS AND DISCUSSION 
  
 Diphenol phenanthroline (Dpp) was used to examine the possibility of controlling 
supramolecular systems created by π- π stacking.  The first compound synthesized was 
Dpp coupled to ferrocene through an ester linkage.  There are two common methods for 
ester formation in literature: the Steglich reactions using DCC/DMAP and the acid 
chloride method. Both approaches were tested.
34,35
 The first attempt at synthesizing Fc-
Dpp (1) with DCC/DMAP did not yield the desired product.  Probable difficulties could 
have arisen by the possibility of polymerization during cyclization as well as inactive 
urea side products may have been formed.  Next the acid chloride approached was tested, 
the synthesis was carried out via refluxing equimolar amounts of ferrocene dicarboxylic 
acid chloride and Dpp in dichloromethane as shown in Scheme 2.1 
13 
 
 
Scheme 2.1  Synthesis of [Fc-Dpp]2 using the acid chloride method.  Equimolar amounts 
of Fc[COCl]2 were reacted with Dpp in dichloromethane giving the desired dimer [Fc-
Dpp]2 (1) in 5% yield. i) Reflux in DCM 
 
The crude product was purified by column chromatography on silica using 1% TEA in 
ethyl acetate as the eluant with an Rf of 0.2.  The isolated compound 1 is poorly soluble 
which complicated the purification.   Compound 1 was examined by 
1
H-NMR in CDCl3.  
There is a plane of symmetry bisecting the molecule and this is observed as equivalent 
peaks in the NMR spectrum Figure 2.1.  Minor impurities and line broadening are 
observed in the NMR spectrum. 
 
Figure 2.1. 
1
H NMR of [Fc-Dpp]2 (1). Aromatic protons of Dpp are observed in the 
range of δ 7.3 to 8.4. Symmetrical Fc protons are observed as two singlets at δ 4.52 and 
5.10. 
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13
C NMR spectroscopy was attempted on [Fc-Dpp]2.  However, due to its low solubility 
and its ease of precipitation, I was unable to acquire reasonable high quality 
13
C NMR 
spectra.  Different solvents were tired but all were found to precipitate the compound 
further.  Mass spectrometry was carried out by electro spray ionization (ESI) giving a M+ 
peak at m/z = 1205 suggesting the presence of the symmetrical dimer.  To gain further 
insight single crystals were grown of compound 1 in the presence of a co-crystallizing 
solvent.  Figure 2.2 shows the x-ray structure of [Fc-Dpp]2 1 with four molecules of 
chloroform which was solved by Gabrielle Schatte, U of S. Selected bond distances and 
angles are  listed in Table 2.2. 
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Figure 2.2. ORTEP drawing of compound 1.  All hydrogen atoms and four chloroform 
molecules are omitted for clarity.  All crystallographic parameters are summarized in 
Table 2.1. 
 
 
The crystal structure shows that the two phenanthroline rings are planar, while the four 
phenol rings are slightly bent out of the plant with respect to the phenanthroline as 
indicated in Figure 2.3. The two phenanthroline rings engage in π stacking interactions 
with distances ranging from 3.81Å for the A-A` distance to 4.02Å for the D-D` distance. 
(Figure 2.3b)  These distances are in the range reported for phenanthroline π-π stacking.36  
The observed offset between the two phenanthroline rings has also been seen before, and 
is described by Umezawa et al. This offset increased the π-π interactions and stabilizes 
the system.
37
 Figure 2.4 shows a top down view looking through both Fc groups, which 
shows that both Fc units are nearly eclipsed having the substituents in a 1,1’-
configuration. In the absence of hydrogen bonding interactions proximal to the Fc group 
there is no preferred orientation of the carbonyls on the Fc groups.  
 
 
Table 2.1. Crystallographic data  1 3 
Empirical formula C76H48Cl12Fe2N4O8 C62H68Cl6FeN6O8 
Formula mass 1682.28 1293.77 
Crystal color, habit orange, plate yellow, plate 
Crystal dimensions [mm] 0.08  0.08  0.05 0.30 x 0.25 x 0.10  
Crystal system triclinic Orthorhombic 
Space group P1¯ [No. 2] P212121 
Unit cell parameters:   
a [Å] 15.0222(8) 17.4544(6) 
b [Å] 15.6770(7) 17.9342(5) 
c [Å] 16.7177(10) 20.5922(9) 
α (°)                                  101.871(3) 90.00 
β (°) 98.999(3) 90.00 
γ (°)                               108.073(3) 90.00 
V [Å3]                                     4079.36(13) 6446.0(4) 
16 
 
Z  2 4 
F(000) 1704 2696 
ρcalcd. [Mg/m3] 1.570 1.333 
μ [mm] 0.919 0.539  
Radiation (Å) Mo-Kα λ = 0.71073  Mo-Kα λ = 0.71073 
Temperature [K] 173(2) 150(2) 
θ range for data collection [°] 3.18-22.98 2.55 to 21.96 
Total reflections 17113 44228 
Independent reflections [Fo2 _ 3σ(Fo2)] 9822(Rint = 0.0692) 7870 [R(int) = 0.0640] 
Observed reflection [Fo2 _ 2σ(Fo2)]  6400 44228 
Data/restraints/parameters 9822/1266/955 7870/758/747 
Absolute structure parameter –0.020(18) (1457) 0.09(6) 
S (Goodness-of-fit on F2) 1.010 1.136 
Final R indices:   
R1
[a]
 [Io _ 2σ(Io)] 0.0614 0.1152 
wR2
[b]
 (all data) 0.1464 0.2590 
Largest difference peak/hole [e– Å3]  1.140 and -.0884 .0714 and -.454 
 
 
Table 2.2.  Selected bond distances (Å) and angles (°) for [FcDpp]2 (1) 
 
Bond Distances 1 
O(4)-C(26) 1.201 (6) 
O(8)-C(48) 1.207 (6) 
O(2)-C(25) 1.195 (7) 
O(6)-C(47) 1.192 (7) 
Av Fe(1) CCp 2.050 (6) 
Av Fe(1) CCp` 2.047 (6) 
Av Fe(2) CCp 2.034 (7) 
Av Fe(2) CCp` 2.039 (6) 
 
Bond Angles  
O5-C47-C41  109.6 (5) 
O1-C25-C27  110.2 (5) 
O3-C26-C32  110.7 (5) 
O7-C48-C46  111.1 (5) 
O6-C47-O5  124.3 (5) 
O6-C47-C41  126.1 (5) 
C71-N3-C6-C52  180.0 (5) 
C11-N1-C1-C13  175.6 (4) 
C12-N2-C10-C19  178.6 (4) 
C72-N4-C70-C58  174.9 (4) 
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Figure 2.3. Molecular structure of compound 1. a) Side view showing the phenanthroline 
system in the plane.  b) End on view with phenanthroline rings stacked over each other 
with π-π stacking. A`-E` denotes the bottom ring of π-π stacking. Distances are given in 
Å. A-A’ = 3.81, B-B’ = 3.99, C-C’ = 3.85, D-D’ = 4.02, E-E’ = 4.02. The top ring is 
slightly offset to the left with respect to the bottom ring, resulting in stronger π 
interactions between the aromatic systems. 
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Figure 2.4. Bottom ferrocene is in E,E conformation while the top ferrocene is in Z,E 
conformation. Torsion angles are given in °. C36-C32-C26-O4 = 3.80°, C42-C46-C48-
O8 = 7.79°, C31-C27-C25-O2 = 4.71°,C37-C41-C47-O6 = 7.01 
 
 
  This leads to having two different rotational isomers, one being E,E and the other 
being Z,E, indication the relative mixture of the carbonyls on the Fc groups with respect 
to each other.  In the E,E isomer both carbonyls are facing out of the molecule, while in 
the Z,E isomer the top ring carbonyl is facing in (Z), while the bottom ring carbonyl is 
facing out (E). Torsion angles between the Cp rings and the proximal carbonyls are in the 
range of 3.8 to 7.8°.  With such small torsion angles for the carbonyls, the interactions 
between Fc and the carbonyls with respect to electronic communication will be high 
because of their π orbital overlap.38 Crystal packing of 1 reveals short contacts between 
the H atoms of the Cp rings and the π systems of the phenanthroline. Such weak C(H)-π 
interactions were observed before and are often significant in that it influences the 
20 
 
packing of the molecules in the solid state (Figure 2.5a) .
30 
 The intermolecular 
interactions of compound 1 are determined by CH-π interactions and not the π-π 
interactions. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5. a) A view down the C axis of compound 1. Blue lines indicating CH-π 
interactions from Cp rings of ferrocene and the phenanthroline π system in the crystal 
packing.    C(H)···π = 3.36Å,  C(H)···π = 3.35Å.   
 
 
 
 Thus the π systems do not stack one on top of each other but instead the packing 
is best described as head to tail.  There are two different distances for the CH-π 
interactions, 3.35 and 3.36Å, these are within the range reported earlier for other CH-π 
interactions.
30 
 Similar packing between Fc-CH and phenanthroline has been seen before 
for similar systems.
39  
The actual
 
packing of the system in reference 39 is not discussed in 
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great detail but it is apparent that the packing of the system is not between π interactions 
but instead between Fc and π interactions.  Figure 2.6 shows the single unit of 1,1’-
Bis{[4-(1,10-phenanthroline-3-yl-ethynyl)-2,5-dipropoxyphenyl] ethynyl}ferrocene in 
which the single crystal structure is determined by π stacking, while the packing is 
determined by Fc CH-π interactions. The single unit shows π stacking between the 
phenanthroline units at distances of 3.360-3.469Å which is slightly smaller then the 
distances seen for compound 1.  This can be justified by the flexibility in the system 
allowing for the phenanthroline to be tighter packed. 
 
 
 
 
 
 
 
 
Figure 2.6.  Single unit of 1,1’-bis{[4-(1,10-phenanthroline-3-yl-ethynyl)-2, 
dipropoxyphenyl] ethynyl}ferrocene.  The two phenanthroline units overlap leading to π-
π interactions in the single unit, while the packing of the system is a zig-zag pattern 
where the CH of Fc interacts with a neighboring phenanthroline.
39
 
  
The next step was to examine the synthesis Fc and Dpp containing macrocycles in which 
peptide spacers separate the Fc and Dpp groups. (Scheme 2.2).  It is believed that peptide 
spacers will enhance both intramolecular and intermolecular interactions, and one might 
assume that a balance will be struck between intramolecular hydrogen bonding of the 
peptides and the π stacking of the aromatic groups.  A number of amino acids were 
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inserted as linkers between the Dpp and Fc giving many new properties to the 
macrocycles. By inserting amino acids we introduced and examine significant 
intermolecular H-bonding interactions, increase the solubility of the macrocycle, as well 
as increase the size of the macrocycle in hopes of synthesizing the monomer.  The first 
step in this synthesis was to couple di-leucine, tri-leucine, glycine, and leucine-alanine to 
Dpp using DCC/DMAP coupling reagents giving the corresponding bis-substituted Boc 
protected Dpp-amino acid conjugates 2, 4, 6, and 7 (Scheme 2.2).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.2. Reaction scheme for compounds 2-7. i) DCC:DMAP/DCM, ii) TFA/DCM, iii) TEA/DCM. 2,4,6,7 are bis-substituted 
Dpp-AA compounds synthesized by ester formation using23 DCC/DMAP coupling reagents. The desired Fc-conjugates 3 and 5 are 
synthesized by high dilution cyclization from the protected Boc-peptide Dpp conjugates 2 and 4.
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Compounds 3 and 5 were then obtained after deprotecting compounds 2 and 4 using 
trifluoroacetic acid (TFA) to remove the Boc group, followed by slow addition of 
Fc[COCl]2 at high dilution, followed by purification by column chromatography to give 
the desired compounds 3 and 5 in 8 and 9% yield, respectively (Scheme 2.2). A sample 
1
H NMR of compound 6 is shown in Figure 2.7. 
 
 
 
 
 
 
 
 
 
Figure 2.7. 
1
H NMR spectrum of Dpp(Gly-Boc)2 (6) in CDCl3. 
 
  
Single crystal diffraction studies of compound 3 were carried out by Michael Jennings at 
UWO.  The ORTEP drawing of compound 3 is shown in Figure 2.8. A summary of the x-
ray data is provided in Table 2.1.  Selected distances and angles are reported in Table 2.3. 
It is important to point out the positional disorder in the distal carbonyls, in which the E,E 
conformation is present in a twofold amount compared to the Z,E conformation.  The 
exact ratio for the two conformations is 63:36% or approximately 2:1. The single unit 
crystal of 3 shows the predicted intramolecular hydrogen bonding between amide and the 
opposite Leu C=O, resulting in a 10-membered hydrogen bonding pattern has been 
observed before for similar ferrocene peptide conjugates,
28 
and is now known as the 
“Herrick pattern”.40 
Dpp 
αC-H2 X2 
NH X2 
Boc X2 
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Figure 2.8. ORTEP of 3. The ferrocene is in a 1,2’-P helical conformation with both 
proximal carbonyls in E,E conformation and two intramolecular hydrogen bonds shown 
in blue. N(67)···O(15)=3.06Å,  N(8)···O(61)= 3.06Å. All crystallographic parameters are 
summarized in Table 2.1. 
 
Table 2.3.  Selected bond distances (Å) and angles (°) for [Fc[Leu2]2Dpp]2 (3) 
 
Bond Distances 3 
O(7)-C(6)  1.259 (14) 
O(69)-C(68) 1.229 (14) 
O(15)-C(14)  1.204 (13) 
O(53A)- C(52A)  1.30 (2) 
O(53B)- C(52B) 1.08 (4) 
Av Fe(1) CCp 2.047 (14) 
Av Fe(1) CCp` 2.041 (14) 
 
Bond Angles  
O(7)-C(6)-C(5)  120.4(11) 
O(69)-C(68)-C(70)  119.8(11) 
O(7)-C(6)-N(8)  120.8(10) 
O(7)-C(48)-C(46)  111.1 (5) 
O(6)-C(47)-O(5)  124.3 (5) 
O(6)-C(47)-C(41)  126.1 (5) 
O(7)-C(1)-C(5)-C(6) 175.6(12) 
O(69)-C(68)-C(70)-C(71) 173.2(12) 
C(34)-N(35)-C(36)-C(45)  177.0(12) 
C(33)-N(32)-C(31)-C(28)  174.6(13) 
26 
  
The supramolecular structure for 3 is controlled by intermolecular hydrogen bonding 
between the proximal carbonyl of ferrocene to the opposite molecule’s amide of the 
second amino acid from ferrocene. There are however, no π-π interactions between the 
phenanthroline groups of adjacent single units. Figure 2.9 shows how three units are 
linked head to tail via hydrogen bonding involving the Fc-CO and the amide NH 
proximal to the phenanthroline of an adjacent molecule. The resulting strand pattern is a 
alternating 10 and 14-membered H-bonded repeat along the strand. This alternating 10 
and14 membered hydrogen bonding pattern resembles that of a antiparrel beta sheet and 
has been discussed before for other ferrocene peptide conjugates.
41,42
  The 10-membered 
ring can be seen by counting the atoms in the intramolecular hydrogen  bonding, while 
the 14-membered ring is seen by the intermolecular hydrogen bonding.  The distance of 
3.06Å for the intramolecular hydrogen bonds and distances of 2.81-2.84Å are both nearly 
identical to those reported earlier for other ferrocene beta sheets, 3.06Å for 
intramolecular and 2.87Å for intermolecular.  Figure 2.9b shows a drawing of an 
antiparrellel beta sheet that shows the 10-14 hydrogen bonding that is seen in figure 2.9a. 
27 
 
Figure 2.9. a) Three units of 3 with leucine side chains removed for clarity, showing intra 
and intermolecular hydrogen bonding with head-to-tailassembly of Fc-peptide-Dpp 
conjugates. Selected intermolecular hydrogen bonds distances: N(59)···O(7’) = 2.81 Å  
N(16’)···O(69) = 2.84 Å. b) Drawing of an antiparrallel β-sheet showing alternating 10- 
and 14-membered rings. 
 
 
Figure 2.10 shows the interaction of strands of 3 with C(H)-π interactions between the 
strands which are shown in Figure 2.9. Distances of 3.1-3.3Å are observed for these 
interactions, much like the interactions observed for 1 which determined the packing. 
Although there are a number of hydrogen bonds present in compound 3 between the 
amide and carbonyl as well as the C(H)-π interactions, there are no π-π interactions 
between the phenanthrolines of adjacent molecules. 
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Figure 2.10. X-ray structure of compound 3 showing C (H)-π interactions between 
hydrogen bonded strands shown in figure 3.0. Leucine side chains have been removed for 
clarity. C (H)···π = 3.13 Å and 3.27  
 
 In similar systems where there is both the ability to hydrogen bond (N-H···O) as 
well as π stack, the leading factor in the packing of the crystal structure is the hydrogen 
bonding.
41
 Figure 2.11 shows the drawing of 3-bromo-N-(2-hydroxy-1,1-
dimethylethyl)benzamide which reported both π-π interactions at distances of 3.54Å as 
well as hydrogen bonding at distances of 1.92, 2.35, and 2.38Å.  .   
 
Figure 2.11.  a) Drawing of 3-bromo-N-(2-hydroxy-1,1-dimethylethyl)benzamide.  
Interactions between aromatic ring are observed as well as hydrogen bonding.  The 
overall crystal structure is a combination of both.
41
 b) Packing of 4 single units.  
Hydrogen bonding and π-π stacking is shown with dashed lines. π-π interactions are 
3.54Å while the three different hydrogen bonds are 1.92, 2.35, and 2.38Å. 
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 The hydrogen bonding is believed to be the leading factor to the crystal packing, 
with π stacking forming once the single molecules are aligned with all possible hydrogen 
bonds first formed. When this is added to the fact that Fc-CH is able to interact with π 
systems it is apparent that the overall packing of the system is a combination of both 
hydrogen bonds as well as CH-π interactions but is not controlled by π-π interactions.  By 
looking at the energies associated with each of the different bonds it can be seen that 
there is a conservation of a small amount of energy with hydrogen bond formation over π 
stacking.  Using the computational number of 1-1.5 kcal/mol
42
 for π-π interactions and 1-
5kcal/mol
43  
for amide hydrogen bonding, it can be seen that there is the possibility for a 
lowering of energy with an increased number of hydrogen bonds.  It also needs to be 
noted that the crystals were grown in nonpolar solvents which would allow more 
intermolecular hydrogen bonds.   
 
Conclusion 
In this chapter, the first series of cyclic ferrocene phenanthroline amino acid and peptide 
conjugates were prepared and studied in solution and the solid state. The peptide 
conjugates engage in intermolecular H-bonding and exhibit C-H π interactions resulting 
in the formation for larger supramolecular assemblies. In the next chapter, the ability of 
phenanthroline peptide conjugates to complex metal ions is explored which is critical for 
the catenation and formation of rotaxanes.  
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CHAPTER 3. 
 
 DIPHENOL PHENANTHROLINE METAL BINDING 
 
 
 In this chapter, metal binding to the phenanthroline group is described. In 
particular, Cu
+
 and Zn
2+
 complexation to the Dpp group are studied by electrochemistry 
and mass spectrometry. Metal complexation is critical en route to peptide catenane 
formation.   
 
 
3.1  METAL BINDING STUDIES 
 
 In the previous chapter, the synthesis of Fc-Dpp and Dpp-amino acid conjugates 
was described. In this chapter, studies aimed at elucidating the interactions of these 
conjugates with Zn and Cu ions will be done.  These metal ions were chosen because of 
their known ability to form complexes with Dpp. In the case of Cu, complexation of Dpp 
conjugates with Cu(I) is facile and in fact is a synthetically useful method for the 
formation of catenanes. Hence, we explored this avenue – without too much success, as 
will be described in Chapter 5. 
 
  
 We studied the reaction of the macrocycle Dpp-Fc (1) with Zn
2+ 
and a number of 
the Dpp-AA compounds (2,4,6,7) with Cu
+
.   For both systems, it is expected that metal 
binding takes place at the Dpp, as reported for other Dpp systems.
44,45  
Figure 3.1 shows 
two phenanthroline metal complexes.  The uses of metal chelation in the compounds 
shown in Figure 3.1 all use the metal ions for supramolecular building.   
31 
 
 
 
 
 
 
 
 
Figure 3.1.  a) Drawing of a phenanthroline polyether macrocycle complexed to Cu(I).
44  
b) Multi-chelate ligand that shows interesting 3D structures when complexed to metal 
ions in different ratios.
45
 
 
By having phenanthroline in the compounds it is possible to predict and design 3-
dimensional structures.  The polyether macrocycle seen in Figure 3.1a has been used in 
catenane synthesis
44
 while the phenanthroline compound in Figure 3.1b has been used as 
a building block for the generation of 3-dimensional structures.
45
 
Metal chelation to the Dpp conjugates (1,2,4,6,7) was investigated electrochemically and 
in the case of the Dpp-peptide conjugates by mass spectrometry.  Unfortunately, we were 
unable to obtain crystalline materials that were suitable to carry out structural 
investigations. 
 
In the case of [Dpp-Fc]2, it is expected that metal coordination to the Dpp ligand will 
cause an interference in the redox properties of ferrocene. Beer et al.
 
has reported that 
there are five different mechanisms that can be present with the different types of 
complexes formed between a redox center and the complexed metal.  
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Figure 3.2. Five different mechanisms for coupling electrochemical and complexation 
reactions. a) Through space b) Bond linkage c) Direct coordination d) Change in 
conformation e) Presence of guest disrupts interaction. 
46 
 
 
The five mechanisms are, through space, direct coordination, bond linkage, change in 
conformation and disruption interactions (Figure 3.2).
 46 
Of these five interactions the 
largest interference is seen when the redox center is both directly bonded to a metal as 
well in close proximity to allow through-space interactions.  Figure 3.3a shows a 
ferrocene compound with two complexation sites which are directly connected to 
ferrocene through the amine.  The resulting interaction between metal ions is a large 
anodic shift in the electrochemical properties.  When a single Zn
+2
 is complexed a shift of 
+320 mV is observed and a larger shift of +720 mV is seen for two complexed Zn
+2 
ions.
47
 A different type of interaction is seen for the compound in Figure 3.3b.  This 
ferrocene bismacrocycle when complexed with K
+ 
ions shows a cathodic shift in the E1/2.  
This is rationalized by a conformational disruption that is thought to occur to allow the 
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K
+ 
ion to be sandwiched between the two macrocycles.  This conformational change 
pushes electrons from the S atom onto the ferrocene group causing a cathodic shift of -60 
mV.
48
   
 
 
 
 
 
 
 
Figure 3.3. a) Ferrocene compound with two coordination sites. Electrochemical studies 
show that a cathodic shift is observed when metal ions are complexed.
47
  b) Ferrocene 
bis-macrocycle that shows a cathodic shift of -60 mV when  a K
+ 
is sandwiched between 
the two macrocycles.
48
 
 
 
 
 
When Na
+
 is complexed to the system, an anodic shift is observed, since coordination of 
the cationic Na
+
 will make it more difficult to oxidize the Fc group. It is believed that due 
to the smaller ionic radius of Na
+
 vs. K
+
, there is no geometric distortion in the complex. 
 
3.1.1  ELECTROCHEMICAL STUDIES OF [Fc-Dpp]2 WITH Zn
2+
 
 Using Dpp for the synthesis of cyclic molecules not only has the advantage of 
having π interactions to build the supramolecular framework but also the ability to 
chelate metal ions.
29
  The interaction of the Fc-Dpp conjugate 1 with Zn
2+
 was studied in 
solution by cyclic voltammetry (CV). This approach should be highly sensitive for Zn
2+
 
complexation and shifts in the halfwave potential E1/2 should be observable. Figure 3.4 
Fe
N
NPh
Ph
Ph
Ph
N
N
N
N
Fe
S
O
O
O
O
O
S
O
O
O
O
O
a) b) 
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shows the CV of compound 1 in DCM and in a 2:1 mixture of DCM and ACN. The 
electrochemical parameters are summarized in Table 3.1.  It is noticeable that the E1/2 for 
compound 1 shifts cathodically as the solvent is changed from E1/2 = 0.944 V to 0.877 V 
in a 2:1 solvent mixture.  This potential shift is due to differences in Fc salvation and was 
observed before. The effects of changing from DCM to acetonitrile has been studied by 
Tsierkezos.
49 
Tsierkezos has shown that in Fc derivatives the change from DCM to 
acetonitrile effects both the E1/2 as well as the ∆E. The addition of acetonitrile was 
necessary to solvate the zinc salt, while DCM was needed to solvate [Dpp-Fc]2.  While 
the complexation of metal ions into a redox active conjugate, such as compound 1, is 
expected to result in an anodic shift of the E1/2, 
50-52 
the opposite is observed in this case. 
Upon addition of Zn
2+
 a further cathodic shift to E1/2 = 0.831 V is observed. The rationale 
provided by others is that the metal ion is able to increase the electron density around 
ferrocene, therefore allowing for the oxidation of ferrocene to occur at lower potentials 
which was discussed earlier with regards to figure 3.2b.
48,53
 Figure 3.4 shows how the 
complexation of a zinc ion with 1.   
 
 
 
 
 
 
Figure 3.4.  Complexation of compound1 with a zinc ion.  The complexation may force a 
change in conformation to align the two phenanthrolines into a bis-bidentating 
arrangement, which in turn changes the position of the oxygens to the ferrocenes. 
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Figure 3.5. CV of 1 at a concentration of 1mM (black) in DCM (Black), in a 2:1 mixture 
of DCM and ACN (green), in a DCM/ACN (2:1) mixture after addition of Zn
2+
 (red).  
Scan rate of 500mV/s on a 25μM gold electrode. Potentials are referenced to Ag/AgCl 
with a Pt counter electrode.  
 
Table 3.1. Electrochemical parameters from CV measurement of conjugate 1 in DCM 
and DCM/ACN (2:1) in the presence and absence of Zn
2+
. Error in all measurements is 
±5 mV 
 ic/ia E1/2 (V) ∆E (V) 
1 in DCM 1.22 0.944 0.164 
1 in 2:1 DCM:ACN 1.22 0.877 0.159 
1 complexed with Zn
2+
 in 2:1 DCM:ACN  1.16 0.831 0.062 
 
. 
 
 
This complexation might force a conformational change in 1 allowing for electrons to 
move from the oxygen in the ester onto ferrocene.  With the complexation of Zn
2+
 to 
conjugate 1 there is a large change in the peak separation ∆E, indicating that the redox 
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event becomes more reversible. Figure 3.6 shows the structure of 
ferrocenylphthalocyanine, which also displays a significant change in the ∆E as a 
function of Zn
2+
 coordination to the ligand. In the presence of Zn, the peak separation 
decreases from ∆E = 226 mV in the absence of Zn2+ to ∆E = 93 mV in the presence of 
Zn
2+
, indicating a more reversible redox behavior when a zinc ion is complexed.
54
 The 
second set of electrochemical experiment was carried out on the Dpp-AA system. Much 
like the cyclic [Dpp-Fc]2 systems there is the potential for metal coordination to the 
nitrogens of the Dpp group.  However unlike the [Dpp-Fc]2 there is no redox probe in the 
Dpp-AA systems.  This results in the need to use a redox active metal to study the 
binding of metal ions.   
 
 
Figure 3.6 a) The separation between the oxidation and reduction peaks in the Zn
2+
-
complex of ferrocenylphthalocyanine is significantly smaller with a ∆E of 93 mV 
compared to the uncomplexed ferrocenylphthalocyanine (b) which has a ∆E of 226 mV.54 
 
 Copper was choosen as the redox active metal to monitor the binding in this 
system.   Compounds 2, 4, 6, and 7, as well as Dpp itself, were complexed to Cu(I). We 
chose copper(I) tetrakisacetonitrile hexaflourophosphate as a soluble Cu(I) salt and 
b) a) 
NN N
N
NNN
N
R
R
R
RR
R
R
R
Zn
NN N
N
NNN
N
R
R
R
RR
R
R
R
RR
R
R
R R
R
R Fe
O
R =
37 
explored ligand to metal  ratios of 1:1 and 2:1. Then CV studies were carried out on the 
complexes to see if there was an observable change in the redox potential of the Cu(I).  
The CV of the Cu(I) complex in ACN is shown in Figure 3.7. It shows a fully reversible 
one-electron oxidation at E1/2 = 0.95 V.  Figure 3.8 shows typical CVs of conjugate 2 in 
the presence of Cu(I) in the ratios of 1:1 and 2:1.  As can be clearly seen from Figure 3.8, 
for a the 2:1 ligand to metal ratio, only one redox active Cu species is present in solution 
having a E1/2 = 0.67 V, while at the 1:1 L:M ratio, two redox signals are observed. One of 
the redox signals is at the identical position as uncomplexed Cu(I), while the other signal 
is at the identical position for a CuL2 complex. This result suggests that after the addition 
of only one equivalent of ligand, there is still free copper present. 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Red line, Cyclic voltammetry of [(CH3CN)4Cu]PF6;  in 0.10 M LiClO4 
solution of acetonitrile at room temperature. Black line, background. Working electrode: 
glassy carbon; scan rate: 100 mV/s. 
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Figure 3.8.  Black line, Cyclic voltammetry of [(CH3CN)4Cu]PF6 and dpp(-Leu3-Boc)2 
(1:1); red line, [(CH3CN)4Cu]PF6 & dpp(-Leu3-Boc)2 (1:2) in 0.10 M LiClO4 solution of 
acetonitrile at room temperature.  Working electrode: glassy carbon; scan rate: 100 mV/s. 
 
 
Table 3.2. CV measurements of Dpp, and for the Dpp conjugates 2,4,6 and 7 at 1:1 and 
1:2 done in 0.10 M LiClO4 solution of acetonitrile at room temperature.  Working 
electrode: glassy carbon; scan rate: 100 mV/s. 
 
 
 
 
 
 
 
 
 
 
 ∆E (V) E1/2 (V) ipa / ipc 
[Cu(CH3CN)4]
+
 0.15 0.95 0.98 
Dpp 1:1 0.11 0.50 0.55 0.93 1.23 1.28 
Dpp 2:1 0.11  0.54  1.13  
2 1:1 0.07 0.19 0.67 0.90 1.18 0.98 
2 2:1 0.10  0.67  0.89  
4 1:1 0.14 0.24 0.67 1.00 0.89 0.90 
4 2:1 0.17  0.70  1.26  
6 1:1 0.10 0.17 0.68 0.94 0.90 0.82 
6 2:1 0.07  0.68  1.00  
7 1:1 0.10 0.18 0.67 0.94 0.83 0.98 
7 2:1 0.10  0.67  1.19  
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Table 3.2 summarized the electrochemical properties of Cu(I) complexes in the presence 
of various M:L stoichiometries. In all cases, the required L:M ratio for the formation of a 
clean complex was 2:1, indicating the formation of a CuL2 complex, as would be 
expected for Cu-Dpp complexes.  The fact that when a 1:1 L:M ratio is tested there is free 
copper and only a 2:1 L:M complex observed and not a  1:1 complex means that  
phenanthroline has a  affinity for 2:1 L:M complexes.  This has been seen before in 
crystal structures where ratios of 1:1 L:M have only grown 2:1 L:M crystals.  Figure 3.9 
shows an example of a phenanthroline compound that forms 2:1 L:M ratio from 1:1 
reactions with cobalt and copper ions.
55
  The redox properties of these CuL2 complexes 
with L = 2, 4, 6, and 7 are essentially identical with E1/2 of about 0.67-0.70 V vs 
Ag/AgCl, indicating that the amino acid and peptide substituents have essentially no 
influence on the redox properties of the metal center.   
 
 
Figure 3.9.  Formation of a 2:1 complex obtained even in the presence of equimolar 
amounts of ligand and metal ion in solution.
55
 
 
  
 As a next logical step, we investigated the metal to ligand stoichiometry of the 
Dpp-AA-Cu complexes by mass spectrometry. In a typical reaction conjugate 6 was 
complexed with copper(I) tetrakisacetonitrile hexaflourophosphate in a ratio of 2:1 Dpp-
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(Gly-Boc)2 to Cu.  Figure 3.9 depicts a cartoon of how two phenanthroline units can 
complex a metal letting the amino acid chains move past the other Dpp, which should 
allow reactions to occur simultaneously on both Dpp-AA compounds. 10 mg of 6 was 
dissolved in 5 ml DCM followed by addition of 0.5 eq of Cu, this was then allowed to stir 
for 10 minutes, resulting in the formation of a blood-red solution, which was then 
examined by mass spectroscopy. Figure 3.11 shows the comparison of calculated and 
experimental MS, indicating the formation of the expected ML2 complex.   
 
 
 
 
 
Figure 3.10. Proposed drawing of how two Dpp-(Gly-Boc)2 units can complex a copper 
ion.  
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Figure 3.11. MS data for Dpp-(Gly-Boc)2 complexed to a copper ion. Top spectra is 
calculated, the bottom is the experimental spectra. Isotope patterns for both the calculated 
and experimental are very close and it is believed that the complex did form 
 
 
Conclusions 
 In this chapter, the coordination behavior of Cu
+
 and Zn
2+ 
were explored. It was 
shown by CV and MS studies that the metal ions clearly complex to the Dpp-peptide 
conjugate presumably by coordinating to the phenanthroline group.  In the next section, 
acyclicpeptide conjugates are explored in an effort to enhance the range of Fc-peptide 
conjugates that will ultimately be linked to the Dpp ligand. 
.
Calculated 
Experimental 
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CHAPTER 4. 
ACYCLIC FERROCENE PEPTIDE COMPOUNDS 
 
 
 This chapter will focus on the synthesis of additional Fc-peptide scaffolds that are 
acylic in an effort to enhance the range of molecules that can ultimately be linked to the 
Dpp group. In particular, the use of diamine linkers will be explored to form bis-Fc 
conjugates which will have a significantly enhanced ring size.  
  
 
 
4.1 RESULTS AND DISCUSSION 
 
 In this chapter, the possibility of exploiting the ferrocene (Fc) group as a scaffold 
to build stable β-sheet mimics will be examined. In particular, the use of diamine peptide 
spacers that are linked to the Fc group will be used. This was thought to facilitate H-
bonding and have enhanced flexibility compared to the related cystamine peptide 
conjugates. The Fc group is a useful organometallic scaffold for the synthesis of 
structural mimics for β-sheets and β-turns and metallocene-peptide conjugates have 
potential applications as potential metallo-drugs
56
 and as components in biosensor 
systems.
57 
 It has been shown that 1,n’-Fc-peptide conjugates adopt an ordered structure 
that is stabilized by intramolecular H-bond formation between the proximal amide NH 
and the carbonyl CO of the adjacent peptide strand as indicated in Figure 4.1. This 
structural motif was first reported by Herrick and coworkers for Fc[Ala-OMe]2.
56  
 
 
43 
 
 
 
 
 
 
Figure 4.1.  Ordered structure observed in compounds of the general formulaFc[CO-AA-
OMe]2, as described by Herrick and coworkers.  There are two equivalent H-bonds 
between the proximal amide NH and the distal CO of the adjacent peptide strand, 
forming a 10-membered H-bond ring. 
 
Similarly, in linear cystamine linked Fc-peptide conjugates, it is the cystamine NH H-
bonding with the Fc-CO that “drives” the formation of supramolecular helicates.58 
Cystamine, although flexible, possesses a degree of rigidity due to the conformational 
preference of the disulfide group.  In contrast, an alkyl linker is expected to have 
enhanced flexibility due to the sp
3
-hybridization of the carbon chain.  We reasoned that 
the incorporation of a diaminoalkane linker into an acyclic Fc-peptide framework should 
enhance the flexibility of the resulting conjugate. In this study Fe[COOH]2 was first 
coupled to either alanine or glycine, followed by partial hydrolysis and finally attached to 
an amine linker (Scheme 4.1).  1,4 butyldiamine was chosen as a suitable linker.    
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Scheme 4.1. Synthesis of diamine linked ferrocene peptides 8 and 9. (i) activation by 
EDC/HOBt in DCM, (ii) Addition of 2.2 eq of H-AA-OMe with 2 eq TEA, (iii) Partial 
hydrolysis of ester using 1eq NaOH in H2O:MeOH for 3h.  (iv) addition of a solution of 
0.4 eq diaminoalkane and triethylamine at 0°C and stirring at room temperature for 20h 
 
It is flexible, which should allow for maximum hydrogen bonding, and in addition has 
sufficient C-atoms in the chain to allow bending of the conjugate and formation of 
intramolecular H-bonding interactions. The length of 1,4 butyldiamine is nearly twice the 
length of a single amino acid.  This length choice would hopefully allow the compound to 
turn back on itself via hydrogen bonds. All compounds were synthesized by amide 
coupling using EDC/HOBt as shown in Scheme 4.1.  Compounds 8 and 9 were obtained 
as light orange solids in low yields (12-20 %). The lower yields may be due to the 
presence of inter-strand “Herrick type” H-bonding in the mono acid intermediate which 
may in fact reduce the reactivity of the carboxy terminus. By using slightly less then 0.5 
equivalents of the diamine linker, the purification can be simplified with the only side 
product being an activated Fc-OBt ester.
59
 
 
In the 
1
H-NMR spectrum, summarized in Table 4.1, compounds 8 and 9 exhibit 
the 1:1:1:1 signal pattern typical of disubstituted ferrocenes corresponding to the four 
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inequivalent Cp protons.  The four ortho protons with the methyl ester substituent show 
more downfield chemical shift than those Cp rings with the amide linkage and all meta 
protons are even further upfield in comparison.  The α-protons are observed at δ 4.08 and 
δ 3.86 for 8 and δ = 4.82 and 4.95 for 9.  As is expected for these conjugates, three 
separate NH resonances are observed ranging from δ 7.95 - 9.23. These relatively 
downfield chemical shifts compare favourably with those of related cystamine linked 
symmetrical Fc-peptides and helical Fc-peptide foldamers reported previously that 
display strong H-bonding interactions.
28,58
 Figure 4.2 shows example of ferrocene peptide 
conjugates that exhibit hydrogen bonding between amides and carbonyls.  Comparisons 
of the amides for Ref 1,2 and 3 to the amide linked Fc peptides are shown in table 4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.  a) Drawing of two cyclic ferrocene dipeptide cystamine compounds that 
show hydrogen bonding which is similar to those seen in compounds 8 and 9. b) Drawing 
of a ferrocene peptide conjugate showing intarmolecular hydrogen bonding. 
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Table 4.1 Selected Spectroscopic data for Fc conjugates 8 and 9 
and Ref 1-3 from Figure 4.2 
Compound 
1
H-NMR  (δ / ppm) 
 NH
a 
 
NH
b 
NH
c αH 
8 8.34 9.23 8.26 4.08 
3.86 
9 
 
8.55 8.97 7.95 4.82 
4.95 
Ref 1
28
 6.70 7.35 8.31  
Ref 2
28
 6.76 7.18 8.27  
Ref 3
60
 5.28 9.94 8.06  
 
As can be seen in table 4.1 the only amide that is not hydrogen bonded is H
a 
for Ref 3.  
The rest of the amides show downfield shifts indicating hydrogen bonding as well as the 
expected hydrogen bonding in compounds 8 and 9.  
 
 
The next step was to study the possibilities of inter and intramolecular hydrogen 
bonding by NMR studies.  A labeling scheme for the amide protons is provided in Figure 
4.3a. A concentration dependent 
1
H-NMR study was first performed on compounds 8,9 
and showed no effects on the amides (Figure 4.3b).  This is indicating that none of the 
amides are participating in intermolecular hydrogen bonding.  
 
 
 
 
 
47 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. a) Labeling scheme for compounds 8 and 9.  b) Concentration dependent 
NMR for 8 showing amides. No shifts are present, indicating there is no intermolecular 
hydrogen bonding present. 
 
VT-NMR studies were then carried out in CDCl3 solution on compounds 8 and 9 
to further investigate the H-bonding behavior of these Fc-conjugates.  All three amides 
display temperature dependent chemical shifts as shown in the 
1
H-NMR spectra amide 
region (Figure 4.4a).  This indicates all three amides involvement in H-bonding, and 
temperature behavior is outlined in Figure 4.4b.  
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Figure 4.4. a) Variable temperature 
1
H-NMR spectra of compound 8 showing the amide 
NH region only. Shifting of all three amides to lower ppm indicates that intramolecular 
hydrogen bonding is present. b) Plot of the δ of the amide NH vs. the temperature in °C. 
 
 The temperature coefficients clearly indicate the involvement of NH
b
 and NH
a
  in H-
bonding (for compound 8: NH
a
 = -7.4 ppb K
-1
; NH
b 
= -6.6 ppb K
-1
; NH
c
 = -4.0 ppb K
-1
, 
compound 9: NH
a
 = -6.2 ppb K
-1
; NH
b 
= -5.5 ppb K
-1
; NH
c
 = -3.5 ppb K
-1
).  The 
temperature coefficients for the Fc-proximal amide NH
c
 is significantly lower, indicating 
potentially weaker H-bonding.  The temperature dependences are similar to other Fc-
peptide systems able to engage in H-bonding interactions.
61
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Figure 4.5. Drawing of a ferrocene peptide having intramolecular hydrogen bonding that 
was studied by variable temperature 
1
H NMR.
61
 
 
 
The temperature coefficients for the compound in figure 4.5 are NH
a 
= +4.2 ppb K
-1
and 
NH
b 
-6.9 ppb K
-1
.  These results are indicating that the amide closest to Fc is hydrogen 
bonded intramolecularly and the value of -6.9 ppb K
-1 
for the temperature coefficient is 
similar for results shown for compound 8 and 9.   
 
The diamine linker amide NH displays the most pronounced dependency of temperature 
on the chemical shift, indicating stronger H-bonding than for the amino acid amide NHs.  
For the intramolecular H-bonding to occur without any intermolecular H-bonding one 
can assume that the introduction of the diamine linker has introduced sufficient flexibility 
into the system to allow formation of the “Herrick H-bonding pattern” which enables also 
the participation of the diamine NHs as proposed in Figure 4.6. By continuing in this 
fashion a long ferrocene peptide diamine system could result in a fairly good 
representation of a β-sheet in solution. 
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Figure 4.6. Proposed solution structure of compounds 6 and 7 based on VT-NMR studies 
showing that all amides are present in intramolecular hydrogen bonding.  Drawing 
illustrates the proposed folding of the compound with ferrocene as a turn inducing 
element.  Dashed lines indicate proposed hydrogen bonding interactions. 
 
 
Next, the electrochemistry of compounds 8 and 9 was studied by cyclic voltammetry 
(CV) in a DCM solution.  During a cyclic voltammetry experiment the ferrocene 
becomes oxidized from an iron 2
+
 species to an iron 3
+
 and back again during the reverse 
reduction scan.  As the oxidation occurs in a system where there are two or more redox 
centers there is the possibility of two different electrochemical scenarios occurring.  The 
first is when the two redox centers act independently of each other and only one 
oxidation peak is observed.  This occurs when there is no electronic communication 
between redox centers and therefore the two ferrocenes will be oxidized and reduced at 
the same potential compared to each other.  The second scenario is when the two redox 
centers are affected by each other.  This effect causes one of the potentials to shift to 
higher potentials indicating that the ferrocenes can sense each other, resulting in 
oxidation of one of the ferrocenes being at higher potentials or more difficult to oxidize.  
This occurs because of the electronic communication between the ferrocenes.  As one 
ferrocene becomes 3
+
, it inherently makes the oxidation of the other ferrocene more 
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difficult.  Figure 4.7 has examples of systems containing two ferrocenes that show 
electronic communication between ferrocene groups, resulting in two oxidation peaks 
during CV experiments. 
 
 
 
 
 
Figure 4.7.  a) Two ferrocene system that exhibits oxidation of ferrocene at 422 mV and 
a second peak at 559 mV.
61
  b) A two ferrocene system in which both ferrocenes show no 
electronic communication to one another resulting in simultaneous oxidation at 20 mV.
62
 
 
The difference in the two examples shown in figure 4.6 is conjugation between the two 
ferrocene moieties. It has been shown as the conjugation between the ferrocene centers 
increases so does the communication.  This effect has led research into molecular wires 
using conjugated ferrocene systems.
63
  
 
With two ferrocene units in both 8 and 9 there is the possibility to have electronic 
communication between the two redox probes but this is not expected because the two 
ferrocene groups are linked by an alkyl chain and conjugation between the ferrocene 
groups is not present.  As a result of no conjugation both systems display a single 
reversible one electron oxidation. Both ferrocenes are oxidized and reduced at the same 
redox potential (Figure 4.8). A variable scan rate experiment was carried out in which the 
CV was recorded at various scan rates. Figure 4.8 shows a linear dependence of the 
square-root of the scan rate with the peak current for compound 8 and 9 as would be 
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expected for redox species in solution (Figure 4.9) Table 4.2 summarizes the 
electrochemical results. 
Figure 4.8. CV of compound 8 with background in red, at a concentration of0.3 mM with 
1.0 M TBAP as the supporting electrolyte. Scan rate of 1.00 V/s on a 25 μM gold 
electrode in DCM. Potentials are referenced to Ag/AgCl with a Pt counter electrode. E1/2 
= 0.80 V, ia/ic = 0.77. ∆E = 0.07V 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9.a) CV of compound 9 at a concentration of 0.3 mM with 1.00 M TBAP  
as the supporting electrolyte. Scan rate of ranging from 0.10 V/s to 25 V/s on a 25 μM 
gold electrode in DCM. Potentials are referencedto Ag/AgCl with a Pt counter electrode. 
b) Graph of relationship of current vs. √scan rate for compound 9. The linear relationship  
indicates that the system is diffusion controlled 
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It has been shown that ferrocene can be used as a scaffold for beta sheet mimics.  By 
selecting a linker of the correct length, flexibility, and hydrogen bonding possibilities, it 
is possible to build ferrocene peptides that are only intramolecularly hydrogen bonded.  
Having only intramolecular hydrogen bonded beta sheets gives the advantage of doing 
electrochemical studies at any concentration and without having to worry about the 
effects of intermolecular hydrogen bonding.  It should be noted that compounds 8 and 9 
can be lengthened by the process of hydrolysis followed by peptide coupling to create a 
larger beta sheet mimic.    
 
Conclusion 
 In this chapter, a series of diamine-linked ferrocene peptides were prepared. 
These molecules display strong intramolecular H-bonding interactions, presumably 
leading to the formation of sheet-like arrangements in solution and the solid state. 
Additional studies will need to be carried out in the future in an effort to investigate the 
structural properties in more detail. 
 
 
Table 4.2. CV measurements of compounds 8  and 9 at a concentration of 0.3 mM with a scan 
rate of 1 V/s on a 25 μM gold electrode in DCM . Potentials are referenced to Ag/AgCl with a Pt 
counter electrode. 
Compound ∆E (mV) E1/2 (mV) ia/ic 
8 71 799 .77 
9 84 812 .88 
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CHAPTER 5. 
 
TOPOLOGICALLY LINKED MOLECULES 
 
 
 Topologically linked molecules are two or more molecules that cannot be 
separated without breaking a covalent bond.  This category of molecules includes 
catenanes and rotaxanes, where cantenanes possess two or more cyclic molecules 
physically connected  through space but not covalently bonded to each other.  Rotaxanes 
are similar to catenanes in that there is a cyclic component but in a rotaxane there is also 
a linear component which passes through the cyclic molecule. This chapter describes the 
synthetic attempts to develop new topologically linked Fc-peptide conjugates based on 
marcocycles developed earlier.  
 
5.1 NATURALLY OCCURRING TOPOLOGICALLY LINKED PROTEINS  
 In recent years there has been the discovery of topologically linked proteins.  
There has always been the prediction that proteins could possibly be mechanically linked, 
but not until the last ten years has there been proof.  In 2000 Wilkoff and co workers 
solved the highly complex crystal structure of the bacteriophage HK97.
65
  The outer 
protein shell (capsid) of the virus was shown to have 72 interlocking rings with each ring 
being topogically linked to either five or six other rings, giving rise to a “chainmail” 
structure  (Figure 5.1).  
55 
  
 
 
    
 
 
 
 
 
 
 
 
Figure 5.1. Crystal structure representation of bacteriophage HK97.  Each colour 
represents one of the 72 subunits which are interlocked to neighboring subunits, giving 
rise to a capsid consisting of fully interlocking proteins.
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 Research has shown that interlocking proteins have an increase in thermal 
stabilization as well as a higher stability to chemical denaturation.
66,67
  These types of 
discoveries have lead researchers to synthesize their own topologically  linked peptides to 
better understand the synthetic pathways and folding nature uses to develop rather 
complicated system.
68,69
 
 
5.2 MOLECULAR MACHINES 
 As technology increases so does the demand for the miniaturization of electronics.  
The goal of creating the smallest, lightest, and most convenient product has lead research 
to examine the use of molecular machines to aid in this goal. Topologically linked 
56 
molecules have been thought to be able to act as molecular machines because of their 
ability to move a single component of the molecule while keeping another part stationary, 
resulting in molecular movement.  When thinking of rotaxanes it is easy to see how if the 
cyclic component moved independently of the linear portion, it could be used as a shuttle.  
The shuttle idea has lead research to use molecular rotaxanes in drug delivery systems,
70
 
memory storage devices,
71 
and to act as switches for electronics.
72
 Figure 5.2 shows a 
rotaxane that is used as a memory storage device similar to a computer’s hard drive.  It is 
believed that because of the size of a single molecule it is possible to reach higher density 
packed memory devices using similar molecules.  
Figure 5.2.  Structure of a rotaxane that is currently being tested for its possibility to 
develop a high density packed memory device.  This particular rotaxane possesses two 
positions for the cyclic component to reside, thus being a potential binary storage 
device.
71
  
 
5.3 SYNTHESIS 
 The synthesis of topologically linked molecules can be carried out in a number of 
ways and will be described briefly.  In any cyclization reaction there is the chance that 
catenanes will be produced, but this percent is very low and is not used.  Here I will 
introduce two variations of the templating technique. In the first approach, two 
independent molecules are coordinated to a metal ion, allowing their reactive groups to 
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cross each other, followed by the cyclization of both molecules.  The second technique is 
synthesis a cyclic compound which then can be templated to an acylic compound, 
followed by cyclization of the acyclic compounds around the starting cyclic compound.  
Figure 5.3 shows how both techniques can be used when templated with a metal.  
Templating can also be used for rotaxane synthesis, if the linear component of the 
rotaxane has a metal coordinating site. 
 
 
Figure 5.3.  Two synthetic techniques described by Sauvage et al.  a) For catenane 
synthesis, the first step is to template the macrocycle with a metal, followed by allowing 
the acyclic component cross past the macrocycle, followed by cyclization of the second 
ring, forming a catenane.  b) Two acyclic components are templated to a metal center, 
followed by cyclization of both acyclic components.
29,62
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 While metal templating can work for systems where there is a metal chelation 
site, some systems do not contain such a site and need different stabilizing effects.  
Vögtle and co-workers have shown how H-bonding involving amides NHs can be used to 
stabilize intermediate systems which can then be reacted to form topologically linked 
systems.
73
 In the synthesis of these amide template systems, the first step is to synthesis a 
macrocycle that contains amide bonds, followed by inserting a guest molecule that can be 
held in the center of the cyclic component through hydrogen bonds. This is then followed 
by either capping the guest molecule resulting in the formation of a rotaxane or its 
cyclization it into a catenane.   
 
Figure 5.4 Possible intermediate in the synthesis of an amide templated rotaxane.  For 
synthesis of rotaxanes it is important that the capped sting does not slide through the 
cyclic molecule once synthesis is complete.  Selection of a large capping agent like trityl 
phenol is used to prevent the sliding of the ring off of the linear molecule.
73 
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Figure 5.4 summarizes the synthesis of a rotaxane by involving the formation of H-
bonding between the cyclic component and the linear component, followed by capping 
with bulky groups. This will prevent loss of the host.
73
   
 
5.4 EXPERIMENTAL ATTEMPTS TO ROTAXANES AND CATENANES 
 As can be seen by research by Sauvage
62
 and Vögtle
73
, it should be possible to 
synthesize topologically linked peptide conjugates making use of compounds 2, 4, 6, and 
7.  Results described in Chapter 3 indicate that when compounds 2, 4, 6 and 7 are 
coordinated to a Cu(I) centre, the Boc protected amide ends will be crossing each other 
allowing for cyclization around each other as indicated in Figure 5.3, and thus catenation 
reactions should be possible. This type of reaction was attempted many times without any 
conclusive results.   
 
 
Scheme 5.1 Attempted catenane reaction using Dpp-(Leu-Ala-Boc)2. i) Addition of 
[Cu(MeCN)4]BF4 ii) Boc removal by addition of 1 mL TFA in 1mL DCM. iii) Slow 
addition of Fc[COCl]2.  Final compound precipitated out of DCM and it was not able to 
be used towards catenane reaction.  
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 The major difficulty arising during the catenation of Dpp-(AA-Boc)2 appears the 
affinity of the N-terminal amino group for the Cu(I) center.  Scheme 5.1 shows an 
attempted catenane reaction using compound 7 and the predicted final product. It is 
believed that upon removal of the Boc group, the N-terminal amino group will complex 
to the Cu(I), which essentially decreases its nucleophilicity to such an extent that it is 
unavailable for the reaction with Fc[CO-Cl]2.  Mass spectrometry experiments were 
carried out on this compound and the results indicate that a copper complex was formed 
with a single Dpp-LA compound. The Boc-group was clearly absent. The complex 
exhibits the appropriate isotope pattern for a copper complex (Scheme 5.1). Other 
attempts, such as adding the Cu(I) after Boc deprotection, did not alter the results and 
essentially the same complex was obtained.  
   
Similar complexation patterns have been described before in the literature and are 
directly relevant to the results of the MS study and shed light on a potential coordination 
environment of the Cu(I) centre in our Dpp complexes. Studies to determine the affinity 
of amino acids to transition metals to help understand the biological function of metals 
have been performed before and have shown similar binding to the predicted system for 
the [CuDpp-LA] complex.
74-76  
Figure 5.5a shows the binding pattern for [Cu(1,3,5-
triaminocyclohexane)(Gly)]
+
 with the corresponding crystal structure in Figure 5.5b.
75
  In 
this system the glycine complexes the Cu ion through the terminal amino group as well as 
the oxygen of the C terminus.  Figure 5.5c shows a drawing of Cu[Aib3]. The 
coordination environment of the Cu ion includes two backbone amides and the N-
61 
terminal amino group along with the oxygen of the C terminus in a square planar 
geometry.  The corresponding crystal structure is shown in Figure 5.5d.
76
  It should be 
noted that when these amino acids are complexed to copper the pKa of the amine and the 
backbone amide NH is reduced significantly.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 a) Drawing of the binding structure for Cu(1,3,5-
triaminocyclohexane)(Gly)]
+
. b) ORTEP plot of Cu(1,3,5-triaminocyclohexane)(Gly)]
+
 
with the deprotanted amine and the carbonyl of glycine complexed to Cu
+
.
75
 c) Drawing 
of Cu(III)Aib3 showing squar planar geometry with three N and one O coordinating to the 
Cu cation. d) ORTEP plot of Cu(III)Aib3.
76
 
 
  
 Scheme 5.2 shows another attempt at a topologically linked system making use of 
cyclo-Fc[CO-Leu]2-1,4butyl diamine. In this synthesis, this Fc-peptide conjugate was 
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used as a precursor for rotaxane synthesis based on Vögtle’s amide hydrogen bond 
synthesis.   
Scheme 5.2. Attempted rotaxane synthesis using cyclic Fc[CO-Leu]2-1,4 butyl diamine 
as the cyclic component followed addition of a linear component with the potential to 
hydrogen bond the amides of leucine followed by the addition of a capping trityl group. 
 
 
 During the attempted synthesis of the rotaxane shown in Scheme 5.2, TLCs were 
employed to monitor the reaction.  At the start of the reaction a single yellow spot was 
observed, after addition of the linear component two yellow spots were observed, one 
with the same Rf as the starting material and a new compound.  After the addition of the 
trityl capping group and work up the crude mixture was purified by column 
chromatography, resulting in the isolation of only the starting ferrocene material with 
nearly 99% recovery.  Because of these results it is believed that the linear component 
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may be interacting with the cyclic ferrocene compound through hydrogen bonding but the 
interaction may not be desired interaction leading to the formation of the rotaxane.  A 
possible explanation is that there is an interaction of the “linear component” with the 
outside amides of the cyclic component or that a potential rotaxane is formed but is 
unstable under the isolation conditions. As column chromatography is performed the two 
components are separated resulting in nearly full recovery of the starting cyclic ferrocene 
component.  Although, unsuccessful in the attempts described here, the possibility to 
synthesize topologically linked peptides should be possible.  Clearly additional work is 
necessary on finding conditions suitable to carry out the ring closure. MS experiments 
clearly show that a Cu-complex is formed. However, it appears that the nucleophilicity of 
the Cu-coordinated amine is too low to ensure reaction even with acid chlorides. It will 
be necessary to investigate this aspect in more detail before a successful peptide rotaxane 
or catenane can be obtained. 
 
Conclusions 
 In this chapter describes our attempts to prepare Fc-peptide-Dpp catenanes and 
rotaxanes. While it appears that the preparation of such systems was unsuccessful, their 
preparation remains a useful goal that should be attempted in the future. 
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CHAPTER 6. 
GENERAL DISCUSSION AND CONCLUSIONS 
 
 
 In this thesis it has shown that a number of new cyclic and acyclic ferrocene 
peptide conjugates have been synthesized and characterized.  By combining ferrocene 
peptides with diphenol phenanthroline it has been possible to synthesize a number of 
cyclic compounds that exhibit both redox properties as well as metal complexing while 
still contributing to cyclic peptide models.  By comparing the crystal structures 
compound 1 which contains no peptides [DppFc]2 to compound 3 that contains four 
lecucine residues Dpp(Leu2)2-Fc it is evident that hydrogen bonding directs the crystal 
packing of these systems while π stacking is secondary and only seen in compound 1 
when there is no possible hydrogen bonding interactions.  The redox property as well as 
the metal binding ability of compound 1 was also studied.  By performing cyclic 
voltammetry experiments on compound 1 it was observed that cationic metal binding 
shows an unusual cathodic shift of roughly 40mV, which has been explained as a 
conformational change resulting in an increase of electron density around ferrocene.  
Compounds 2,4,6 and 7 were also studied electrochemically for their binding ability to 
copper. In this study different ratios of the L:M were studied by cyclic voltammetry.  The 
ratios of 2:1 and 1:1 were tested to observe how the copper was being complexed.  It was 
evident from the electrochemistry that Dpp compounds have a high tendency to form 
65 
dicomplexed species even when a ratio of 1:1 L:M is used.  This result was then backed 
up by literature where only dicomplexed Dpp systems have been crystallized even when 
a 1:1 L:M ratio was used, as well as the mass spectrometry results that always show a 
dicomplexed species present.   
 
Future research recommendations in this area can be seen in the development of 
monitoring of ions.  The Dpp unit of these compounds allow for a size constrained 
complexation site while ferrocene has been shown to be affected by the complexation of 
metals.  If a change in size effects the conformational change of the system then it should 
be possible to monitor different metals based on their size and perhaps their charge.  A 
second future research area was discussed earlier in chapter 5.  Topologically linked 
molecules can be synthesized from the cyclic compounds 3 and 5.  This research area 
however can be seen as fairly complicated both because of the low yields of cyclization 
as well as the reactivity of amides to the metals that are needed in catenation reactions. 
 
In a second study of ferrocene peptide synthesis a β-sheet model was made by combining 
butyl diamine with either two Fc-1-(gly-OMe)-1`-(gly-OH) or two Fc-1-(ala-OMe)-1`-
(ala-OH).  In doing this it was possible to develop a completely intramolecular hydrogen 
bonded system that is completely independent to concentration while being dependent on 
temperature.  For this to be useful suitable peptides could be chosen that allows for 
salvation of a ferrocene peptide system in water, followed by electrochemistry of 
potential beta breakers could be examined to screen or predict disruptions of the 
intramolecular hydrogen bonding.   
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CHAPTER 7. 
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EXPERIMENTAL 
 
6.1 GENERAL PROCEDURE 
 All experiments were performed using CH2Cl2 that was distilled and dried (CaH2) 
prior to use.  The coupling agents used for amide bond formation, N-ethyl-N′-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC۰HCl) and 1-
hydroxybenzotriazole hydrate (HOBt) (Advanced ChemTech) were used as received.  H-
Leu-OMe۰HCl, triethylamine, sodium hydroxide  (Sigma Aldrich) were also used as 
received.  Ferrocene dicarboxylic acid (Fc[COOH]2) was synthesized as described 
previously.
77
 Ferrocene diacid chloride (Fc[COOCl]2) was synthesis as described 
previously 78. Dpp was synthesized according to reference 79. All reactions were carried 
out in air unless specified.  For column chromatography a column was packed 15-25 cm 
high with 230-400 mesh silica gel (Silicycle).  Nuclear Magnetic Resonance (NMR) 
spectra were recorded on a Varian Mercury 400 spectrometer operating at 400.1 MHz for 
1
H-NMR and 100.6 MHz for 
13
C-NMR. Both 
1
H-NMR and 
13
C-NMR were reported in 
ppm relative to tetramethylsilane (TMS, δ = 0).   The 1H-NMR spectra were referenced to 
the residual signals of CHCl3 (δ 7.26) or CH3OH (δ 3.31).  All 
13
C-NMR were referenced 
to the CDCl3 signal (δ 77.23) or CH3OH (δ 49.00).  2D-COSY experiments were used to 
complete assignments in the 
1
H-NMR spectra.  Mass spectrometry analysis was carried 
out using a Finnigan MAT 8200 (Doug Hairsine of the University of Western Ontario 
Chemistry Department).  Infrared spectra were obtained on a Bruker Tensor 27 FTIR 
spectrometer. Cyclic voltammetry experiments were performed using a CHI900b 
instrument at room temperature (22 ± 2 °C).  A working microelectrode of carbon was 
used against an Ag/AgCl reference electrode and platinum counter-electrode.  All 
68 
samples were prepared as 0.5 mM solutions in distilled dichloromethane with 0.2 M 
tetrabutylammonium perchlorate (TBAP) as a supporting electrolyte.  The scan rate was 
varied from 100 – 2500 mV s-1 for all compounds.   
 
Preparation of [FcDpp]2 (1) 
 
 
 
 
 
 
 
A solution of ferrocene diacid chloride 310 mg (1 mmol)  and 366 mg (1 mmol) Dpp was 
stirred in 200 mL DCM.  This solution was then refluxed for 10h, followed by an 
aqueous workup, involving consecutive washings with saturated NaHCO3, 10% citric 
acid, and finally distilled water. The organic phase was collected, dried of Na2SO4, 
filtered and evaporated to dryness. The crude product was then purified by column 
chromatography with a mobile phase of 1% TEA in EtOAc.  The final product is only 
soluble in chlorinated solvents and has shown some impurities in NMR.  (Rf = 0.20) (55 
mg, 5%). 
1
H NMR (CDCl3, δ in ppm): 8.40 (8 H , d, Dpp) ; 8.05 (4 H, d, Dpp) ; 7.92 (4 H, d, Dpp) 
; 7.58 (4 H, s, Dpp) ;  7.40 (8 H, d, Dpp) ; 5.10 (8 H, s, Cp)  ; 4.59 (8 H, s, Cp).  
MS (ESI): calculated for C72H44Fe2N4O8 1204.1 ; found 1205.3 [M+1]
+
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Preparation of Dpp[Leu2Boc]2 (2) 
 
 
 
 
 
 
 
To a stirring solution of 183 mg (0.5 mmol) Dpp in 100 mL DCM, 378 mg (1.1 mmol) 
Boc-Leu2-OH was added with TEA (0.25 mL) and allowed to cool on ice.  134 mg (1.1 
mmol) DMAP and 340 mg (1.5 mmol) DCC were added sequentially and the reaction 
was removed from the ice and allowed to stir for 24h. The urea was filtered off, the 
solution subjected to aqueous workup described above and the organic phase evaporated 
to dryness. This is followed by column chromatography on SiO2 (10%EtOAc:DCM. (1:9) 
(Rf = 0.60) (200 mg, 40%). 
1
H NMR (CDCl3, δ in ppm): 8.45 (4 H, d, Dpp), 8.30 (2 H, d, Dpp), 8.27 (1 H, d, NH), 
8.09 (2 H, d, Dpp), 7.77 (2 H, s, Dpp), 7.31 (4 H, d, Dpp), 7.71 (1 H, s, NH), 7.03 (1 H, d, 
NH), 6.57 (1 H, d, NH), 4.99-4.85 (2 H, m, αCH), 4.63-4.44 (2 H, m, αCH), 4.19-3.99 (4 
H, m, αCH),, 1.43 (18 H, s, Boc), 0.97-0.85 (24 H, d, Leu-CH3). MS (ESI): calculated for 
C58H76N6O10 1016.5 ; found 1017.3 [M+1]
+
 
 
Preparation of Fc[Leu2]2Dpp (3) 
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Compound 2 180 mg (0.177 mmol) was dissolved in 2 mL DCM and 2 mL TFA was 
added.  After 30 minutes, the mixture was dried in vacuo. Excess TFA was removed by 
repeated drying in vacuum and addition of DCM. The resulting solid was then dissolved 
in 600 mL in DCM and TEA and 100 mg K2CO3 were added to ensure the solution was 
at basic conditions. The resulting clear solution was then cooled and allowed to stir for 10 
minutes.  Ferrocene diacid chloride 55 mg ( 0.177 mmol) was then added drop wise over 
24hrs and allowed to stir an additional 24h.  The volume of the solution was then reduced 
to 100 mL and was washed with saturated NaHCO3, 10% citric acid, and finally distilled 
H2O. The organic phase was collected, dried over anhydrous Na2SO4, filtered, and then 
dried in vacuo. The compound was then purified by preparatory plate chromatography 
with a mobile phase of 4:1 EtOAc:Hex. (Rf = 0.63). The final product is believed to be 
reasonably clean with only minor impurities of side products from the reaction 
determined by NMR.  Yield = 15 mg, 9%) 
1
H NMR (CDCl3, δ in ppm): 8.47 (4 H, d, Dpp), 8.44 (1 H, d, NH), 8.24 (2 H, d, Dpp), 
8.01 (4 H, m, Dpp), 7.72 (2 H,s, Dpp), 7.32 (1 H, d, NH), 7.24 (1 H, d, NH), 7.15 (2 H, d, 
Dpp), 6.60 (1 H, d, NH),  4.81 (2 H, s, Cp), 4.69 (2 H, s, Cp), 4.59 (2 H, d, αCH), 4.45 (2 
N
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H
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H, s, Cp), 4.28 (2 H, s, Cp), 3.98 (2 H, d, αCH), 1.95-1.77 (12 H, m, Leu-CH-CH2), 1.05-
0.85 (24 H, m, Leu-CH3). MS (ESI): calculated for C60H66FeN6O8 1254.4; found 1255.8 
[M+1]
+
 
 
Preparation of Dpp[Leu3Boc]2 (4) 
 
 
 
 
 
 
 
To a stirring solution of Dpp 934 mg (2.6 mmol) in 100 mL DCM, Boc-Leu3-OH 2.8 g 
(0.1 mmol) was added with TEA 0.94 mL and allowed to cool on ice. DMAP (748 mg, 
6.0 mmol) and DCC 1.5 g (6.1 mmol) were added sequentially as solids and the reaction 
was removed from the ice and allowed to stir for 24h.  The resulting solution was dried in 
vacuo and filtered to remove urea side products.  The solution was then washed with 
saturated NaHCO3, 10% citric acid, and finally distilled H2O and the organic phase was 
collected, dried over anhydrous Na2SO4, filtered and evaporated to dryness.  Purification 
of the product was done by column chromatography (20%EtOAc:DCM).(Rf = 0.70). 
Yield = 1.8 g, 56 %. 
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1
H NMR (CDCl3, δ in ppm): 8.45 (4 H, d, Dpp), 8.31 (2 H, d, Dpp), 8.11 (2 H, d, Dpp), 
7.78 (2 H, s, Dpp),  7.29 (2 H, s, NH), 7.32 (4 H, d, Dpp), 7.07 (1 H, d, NH), 6.70 (1 H, d, 
NH), 6.53 (1 H, d, NH), 6.07 (1 H, d, NH),  4.87 (2 H, m, αCH), 4.67 (1 H, m, αCH), 
4.52 (1 H, m, αCH), 4.08 (2 H, m, αCH), 1.85-1.68 (18 H, m, Leu-CH-CH2), 1.47 (18 H, 
s, Boc), 1.01-0.87 (36 H, m, Leu-CH3). MS (ESI): calculated for C70H98N8O12 1242.7; 
found 1253.5 [M+1]
+
 
 
Preparation of Fc[Leu3]2Dpp (5) 
 
 
 
 
 
 
 
The procedure is identical to that described for the preparation of compound 2. 
Compound 4 400 mg (0.31 mmol) was dissolved in 2 mL DCM and 2mL TFA was 
added.  Ferrocene diacid chloride 97 mg (0.31mmol) was added over 24h. Preparatory 
plate chromatography (SiO2) with a mobile phase of 4:1 EtOAc:Hex. (Rf = 0.68) gave a 
yield of 30 mg (8%).  The final product is believed to be reasonably clean with only 
minor impurities of side products from the reaction determined by NMR 
1
H NMR (CDCl3, δ in ppm): 8.41 (4 H, d, Dpp), 8.32 (1 H, d, NH),  8.26 (2 H, d, Dpp), 
8.06 (2 H, d, Dpp), 7.98 (1 H, d, NH),  7.75 (2 H, s, Dpp),  7.25 (4 H, d, Dpp), 7.06 (1 H, 
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d, NH), 6.80 (2 H, d, NH), 6.34 (1 H, d, NH),  4.90-4.80  (2 H, m, αCH), 4.79-4.71  (3 H, 
m, αCH, Cp), 4.69-4.59 (3 H, m, αCH, Cp),  4.49-4.42 (1 H, m, αCH), 4.38-4.20 (2 H, m, 
Cp), 4.29-4.22 (3 H, m, αCH, Cp), 1.90-1.72 (18 H, m, Leu-CH-CH2), 1.00-0.95 (36 H, 
m, Leu-CH3). MS (ESI): calculated for C72H88FeN8O10 1280.6; found 1281.5 [M+1]
+
 
 
Preparation of Dpp[GlyBoc]2 (6) 
 
 
 
 
 
 
 
To a stirring solution of Dpp 183 mg (0.5 mmol) in 100 mL DCM, Boc-Gly-OH 192 mg 
(1.1 mmol) was added with TEA 0.25 mL and allowed to cool on ice. DMAP 134 mg 
(1.1 mmol) and DCC 340 mg (1.5 mmol) were added sequentially and the reaction was 
removed from the ice and allowed to stir for 24h.  The resulting solution was dried by 
vacuum and filtered to remove urea side products.  The reaction mixture was then 
subjected to a standard aqueous work described above. The organic phase was collected, 
dried over anhydrous Na2SO4, filtered, and evaporated to dryness. After column 
chromatography (SiO2, 10%EtOAc:DCM.(Rf = 0.60), 203 mg of the desired product was 
obtained  (Yield = 60%) 
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1
H NMR (CDCl3, δ in ppm): 8.45 (4 H, d, Dpp), 8.30 (2 H, d, Dpp),  8.09 (2 H, d, Dpp), 
7.77 (2 H, s, Dpp), 7.31 (4 H, d, Dpp), 5.08 (2 H, m, NH), 4.24 (αCH2), 1.43 (18 H, s, 
Boc). MS (ESI): calculated for C38H38N4O8 678.2; found 679.4 [M+1]
+
 
 
Preparation of Dpp[Leu-AlaBoc]2 (7) 
 
 
 
 
 
 
 
 
The synthetic procedure is identical to that described for compounds 2, 4, and 6. 
Amounts used: Dpp 183 mg (0.5 mmol) in 100 mL DCM, Boc-Leu-Ala-OH 332 mg (1.1 
mmol) DMAP 134 mg (1.1mmol), DCC 340 mg (1.5mmol) Column chromatography: 
SiO2, 10%EtOAc:DCM.(Rf = 0.60). Yield: 265 mg, 55% 
1
H NMR (CDCl3, δ in ppm): 8.45 (4 H, d, Dpp), 8.30 (2 H, d, Dpp), 8.27 (2 H, d, Dpp), 
7.85 (2 H, s, Dpp), 7.34 (4 H, d, Dpp), 6.65 (2H, d, NH), 5.02 (2H, d, NH),  4.99-4.85 (2 
H, m, αCH), 4.25 (2 H, m, αCH), 1.60 (6 H, m, Leu-CH-CH2), 1.49 (18 H, s, Boc), 1.40 
(6H, d, Ala-CH3), 1.03 ( 12H, m, Leu-CH3). MS (ESI): calculated for C52H64N6O10 932.4; 
found 933.7 [M+1]
+
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Preparation of [Fc(n'-Ala-OMe)(1-Gly)]2-1,4-butyl diamine (8) : 
 
 
 
 
 
 
 
 
 
 
 
Fc(n`-Gly-OMe)(1-Gly-OH) was prepared by partial hydrolysis of Fc(1-n`-Gly-OMe)2. 
Fc(n`-Gly-OMe)(1-Gly-OH) 40mg (0.1 mmol) is stirred in 50 mL DCM with 1.5 eq EDC 
24 mg (0.15 mmol) and HOBt (21 mg, 0.15 mmol) for 30 min.  After the activation of the 
acid to a activated ester is completed the solution is diluted to 200 mL DCM and a 
solution of 0.5 eq of 1,4-butyl diamine 4 mg (0.05 mmol) is added dropwise.  The 
solution is then stirred overnight, evaporated to dryness and subjected to an aqueous 
workup as described above. The organic phase was collected, dried over anhydrous 
Na2SO4, filtered, and evaporated to dryness.  The compound was then purified by column 
chromatography with a mobile phase of 95:5 CHCl3:MeOH.  (RF = 0.32). Yield = 12%  
(0.009 g) 
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1
H NMR (CDCl3, δ in ppm): 9.33 (2 H, d, Gly-NH), 8.43 (2 H, d, Linker-NH), 8.34 (2 H, 
d, Gly-NH), 4.90(4 H, s, Cp), 4.84 (4 H, s, Cp), 4.47 (4H, s, Cp), 4.39 (4H, s, Cp), 4.14 (4 
H, d, αCH2), 3.93 (4 H, d, αCH2), 3.83 (6 H, s, OMe), 3.41 (4H, s, Linker-CH2), 1.72 
(4H, s, Linker-CH2).  MS (ESI): calculated for C38H45Fe2N6O10 857.2 ; found 858.2 
[M+1]
+
 
 
Preparation of [Fc(n'-Ala-OMe)(1-Ala)]2-1,4-butyl diamine (9) : 
 
 
 
 
 
 
 
 
 
 
 
The procedure is identical to that described for compound 8.  Fc(n`-Ala-OMe)(1-Ala-OH) 
was prepared by partial hydrolysis of Fc(1-n`-Ala-OMe)2.  Amounts: Fc(n`-Ala-OMe)(1-
Ala-OH) 25 mg (0.05 mmol), 50 mL DCM with 1.5eq EDC 10 mg (0.075 mmol) and 
HOBt 10 mg (0.075 mmol) Dilution to 200 mL DCM, 0.5eq 2 mg (0.025 mmol) of 1,4-
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butyl diamine. Purification by column chromatography 95:5 CHCl3:MeOH (RF = 0.32). 
Yield = 20% (0.011g). 
1
H NMR (CDCl3, δ in ppm): 8.97 (2 H, d, Ala-NH), 8.56 (2 H, d, Linker-NH), 7.95 (2 H, 
d, Ala-NH), 4.93(6 H, s, Cp), 4.91 (2 H, m, αCH), 4.89 (2H, d, Cp), 4.78 (2H, m, αCH),  
4.58 (2 H, s, Cp), 4.34 (4 H, s, Cp), 4.32 (2 H, s, Cp), 3.84 (6 H, s, OMe), 2.95 (4H, d, 
Linker-CH2), 1.86 ( 4H, m, Linker-CH2), 1.56 (6 H, d, Ala-CH3), 1.35 (6 H, d, Ala-
CH3).MS (ESI): calculated for C42H53Fe2N6O10 913.3; found 914.1 [M+1]
+
.   
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